Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
Clinical trial NCT06821087 · COMPLETED
Trial details
- NCT number
- NCT06821087
- Sponsor
- University of Texas at Austin
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-28
- Primary completion
- 2026-06-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.